Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
European Pharmaceutical Journal
AHEAD OF PRINT
Open Access
Development and Characterisation of Valsartan Immediate Release Dosage Form Using Solubility Enhancement Technique
R. Saripilli
R. Saripilli
,
P. Teella
P. Teella
and
Kalakonda S. Nataraj
Kalakonda S. Nataraj
| Jun 07, 2024
European Pharmaceutical Journal
AHEAD OF PRINT
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Original Paper
Published Online:
Jun 07, 2024
Page range:
-
Received:
Dec 29, 2023
Accepted:
Apr 04, 2024
DOI:
https://doi.org/10.2478/afpuc-2024-0005
Keywords
Immediate release tablets
,
valsartan
,
β-cyclodextrin
,
poly vinyl pyrrolidone K30
,
Poloxamer 188
,
Physical mixture
© 2024 R. Saripilli et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
R. Saripilli
Centurion University of Technology and Management, IDCO Land
INDIA
P. Teella
M. Pharm, Aditya College of Pharmacy
Kalakonda S. Nataraj
Shri Vishnu College of Pharmacy